An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration

被引：0
作者：
David Chiang
M. Cecilia Berin
机构：
[1] Icahn School of Medicine at Mount Sinai,Pediatric Allergy and Immunology
来源：
Current Allergy and Asthma Reports | 2015年 / 15卷
关键词：
Food allergy; Anaphylaxis; Desensitization; Tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Allergen immunotherapy for the treatment of food allergy has been a subject of intensive study within the last 10 years. After an unsuccessful attempt with subcutaneous immunotherapy for peanut allergy, other routes with varying degrees of safety and efficacy have been tested for peanut, milk, and egg allergies. In this review, we summarize the results to date with oral immunotherapy, sublingual immunotherapy, and epicutaneous immunotherapy for the treatment of food allergy. While results of immunotherapy trials are promising, increases in efficacy are commonly associated with an increased side effect profile. There is a need for additional research beginning at the preclinical level to develop safe and effective treatments for food allergy.
引用
收藏
相关论文
共 267 条
[11]  
Lahr J(2010)Oral peanut immunotherapy in children with peanut anaphylaxis J Allergy Clin Immunol 127 654-243
[12]  
Rule R(2011)A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response J Allergy Clin Immunol 367 233-205
[13]  
Bock A(2012)Oral immunotherapy for treatment of egg allergy in children N Engl J Med 119 199-455
[14]  
Leung D(2007)Egg oral immunotherapy in nonanaphylactic children with egg allergy J Allergy Clin Immunol 129 448-1304
[15]  
Oppenheimer JJ(2012)The safety and efficacy of sublingual and oral immunotherapy for milk allergy J Allergy Clin Immunol 383 1297-21
[16]  
Nelson HS(2014)Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial Lancet 1 15-102
[17]  
Bock SA(2015)Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up J Allergy Clin Immunol Pract 43 92-141
[18]  
Christensen F(2013)Peanut oral immunotherapy: is it ready for clinical practice? J Allergy Clin Immunol Pract 44 130-156
[19]  
Leung DY(2013)Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test Clin Exp Allergy J Br Soc Allergy Clin Immunol 46 154-74
[20]  
Schofield A(2014)Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children Clin Exp Allergy J Br Soc Allergy Clin Immunol 106 73-1157
12345678910